Legend Biotech reports Q3 2026 results, CARVYKTI sales up 36%, names new CEONov 10Quarterly updateLegend Biotech Corp
Legend Biotech gets FDA IND clearance for in vivo CAR-T candidate LB2501Oct 15Regulatory milestoneLegend Biotech Corp
Legend Biotech shareholders back directors, auditor, and share plan increase at 2026 AGMSep 24PeopleLegend Biotech Corp
Legend Biotech seeks shareholder approval to add 19.1 million shares to RSU planAug 18PeopleLegend Biotech Corp